» Articles » PMID: 29366678

Galectin-3 Enhances Avian H5N1 Influenza A Virus-Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2018 Jan 26
PMID 29366678
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Highly pathogenic avian influenza A H5N1 virus causes pneumonia and acute respiratory distress syndrome in humans. Virus-induced excessive inflammatory response contributes to severe disease and high mortality rates. Galectin-3, a β-galactoside-binding protein widely distributed in immune and epithelial cells, regulates various immune functions and modulates microbial infections. Here, we describe galectin-3 up-regulation in mouse lung tissue after challenges with the H5N1 influenza virus. We investigated the effects of endogenous galectin-3 on H5N1 infection and found that survival of galectin-3 knockout (Gal-3KO) mice was comparable with wild-type (WT) mice after infections. Compared with infected WT mice, infected Gal-3KO mice exhibited less inflammation in the lungs and reduced IL-1β levels in bronchoalveolar lavage fluid. In addition, the bone marrow-derived macrophages (BMMs) from Gal-3KO mice exhibited reduced oligomerization of apoptosis-associated speck-like proteins containing caspase-associated recruitment domains and secreted less IL-1β compared with BMMs from WT mice. However, similar levels of the inflammasome component of nucleotide oligomerization domain-like receptor protein 3 (NLRP3) were observed in two genotypes of BMMs. Co-immunoprecipitation data indicated galectin-3 and NLRP3 interaction in BMMs infected with H5N1. An association was also observed between galectin-3 and NLRP3/apoptosis-associated speck-like proteins containing caspase-associated recruitment domain complex. Combined, our results suggest that endogenous galectin-3 enhances the effects of H5N1 infection by promoting host inflammatory responses and regulating IL-1β production by macrophages via interaction with NLRP3.

Citing Articles

Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.

Xu J, Zhang W, Fu J, Fang X, Gao C, Li C Mil Med Res. 2024; 11(1):78.

PMID: 39676169 PMC: 11648306. DOI: 10.1186/s40779-024-00581-0.


Mechanistic Insights into Influenza A Virus-Induced Cell Death and Emerging Treatment Strategies.

Sun Y, Liu K Vet Sci. 2024; 11(11).

PMID: 39591329 PMC: 11598850. DOI: 10.3390/vetsci11110555.


Galectin-3 disrupts tight junctions of airway epithelial cell monolayers by inducing expression and release of matrix metalloproteinases upon influenza A infection.

Iqbal M, Feng C, Zong G, Wang L, Vasta G Glycobiology. 2024; 35(1).

PMID: 39569730 PMC: 11727335. DOI: 10.1093/glycob/cwae093.


TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3.

Kim K, Lee C, Kim H, Gu S, Yoon H, Won S Commun Biol. 2024; 7(1):1090.

PMID: 39237613 PMC: 11377825. DOI: 10.1038/s42003-024-06762-w.


Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2.

Saikh K, Anam K, Sultana H, Ahmed R, Kumar S, Srinivasan S Int J Mol Sci. 2024; 25(15).

PMID: 39125989 PMC: 11313481. DOI: 10.3390/ijms25158421.